Top Neurovascular Device Companies
.png)
Published: August 2024
We analyzed over 50 neurovascular device companies that are engaged in offering more than 350 neurovascular devices. In this article, discover five top neurovascular device companies and their capabilities in neurovascular devices market.
Neurovascular disorders are among the top five life-threatening conditions, accounting for approximately 15 million new cases and five million mortalities, annually. This increased incidence of neurovascular disorders can be attributed to underlying pathological conditions, such as diabetes, hypertension and obesity along with poor lifestyle. Currently, several surgical methods, such as open neurosurgery, microsurgery, craniotomy and bypass surgery are being used for the treatment of neurovascular disorders. However, these methods are proven to be less effective, owing to the fact that they are complex and time-consuming, have low success rates and delayed recovery. In order to address these problems associated with the conventional surgical methods, neurovascular devices, a minimally invasive and targeted endovascular technique, has emerged as a potential approach of treatment.
The neurovascular devices have attracted significant attention on the grounds of their success rate in improving life expectancy and healthcare outcomes. Neurovascular devices encompass intracranial stents, embolic coils, flow diverters, balloon occlusions, and accessory devices. It is worth highlighting that neurovascular device designs are flexible and are continuously improving to transform neurovascular disease treatment and enhance patient outcomes. However, in the recent past the industry has been hit by some serious device recalls, which may raise concerns about patient safety.
Roots Analysis has conducted an exhaustive study on Neurovascular Devices Market featuring the current market landscape and future opportunity for the companies engaged in offering neurovascular devices, over a span of 11 years.
Table of Contents
Below, we have listed (in alphabetical order), the top five Neurovascular Device Companies:
- Johnson & Johnson
- Medtronic
- MicroVention
- Penumbra
- Stryker
Interested in exploring all 50+ Neurovascular Device Companies and their recent initiatives?
Discover Below the Details on 5 Top Neurovascular Device Companies
Let us deep dive to understand the activity of the 5 top neurovascular device companies (with an employee base of more than 1,000 individuals and offering more than 20 neurovascular devices) in the Neurovascular Devices market. It is essential to note that the selection of top players can differ substantially according to the defined criteria.
Johnson & Johnson Creating a Neurovascular Brand Under Cerenovus; Hit by a Recent FDA Recall
1. Johnson & Johnson
Johnson & Johnson is a globally recognized healthcare company engaged in the development of Innovative Medicine and MedTech. With over 100 years of legacy in the healthcare domain, the company operates across three principal segments: pharmaceuticals, medical devices and consumer health. Within the MedTech segment, the company offers solutions for orthopedics, surgery, interventional solutions and vision correction. The company strives to offer continuum of care to patients with neurovascular disorders through various technologies and medical devices developed within their business segment CERENOVUS.
Johnson & Johnson: Company Overview
| Key Parameters | Description |
| Company Logo |  |
| Year of Establisment | 1886 |
| Number of Employees | 10,001+ |
| Headquarter |  |
| Neurovascular Devices |
|
Recent Developments:
In April 2024, FDA issued a recall of Cerebase DA Guide Sheath catheter used for delivering interventional devices to the blood vessels in the brain. It was a class I recall under impacting 1,343 devices.
In July 2023, Johnson & Johnson presented its latest stroke management activities at Society of NeuroInterventional Surgery (SNIS) 2023 Annual Meeting. Further, in July 2022, company participated in Society of NeuroInterventional Surgery (SNIS) 2022 Annual Meeting to represent new innovations to improve its stroke portfolio.
Further details on recent initiatives taken by Johnson & Johnson and other neurovascular device companies have been provided in detail in the report.
In November 2023, Medtronic Launched a Neuroscience Center of Excellence, along with Alameda Healthcare in Egypt
2. Medtronic
Medtronic is a global leader in healthcare technology, focused on developing innovative diagnostic and therapeutic solutions for more than 70 health conditions. Additionally, the company operates through four business segments namely cardiovascular, diabetes, medical surgical and neuroscience. Under its neuroscience division, the company provides advanced healthcare products which can be used for minimally invasive neurointerventional procedures for the treatment of distinct neurovascular disorders. Further, it is worth highlighting that the wide range of products offered by the company serves nearly 72 million patients across 150 countries.
Medtronic: Company Overview
| Key Parameters | Description |
| Company Logo |  |
| Year of Establisment | 1949 |
| Number of Employees | 10,001+ |
| Headquarter |  |
| Neurovascular Devices |
|
Recent Developments:
In December 2023, the company established a patient registry named INSPIRE-S to collect real world evidence on two devices from its neurovascular devices portfolio that are used for treatment of acute ischaemic stroke. In April 2023, Medtronic entered into strategic partnership with Qure.ai to revolutionize stroke management, by integrating latter company’s solutions into comprehensive and primary stroke center.
Further details on recent initiatives taken by Medtronic and other neurovascular device companies have been provided in detail in the report.
In 2006, Terumo Acquired MicroVention in Order to Strengthen its Technology and Product Portfolio
3. MicroVention
MicroVention is a rapidly evolving medical device company involved in the development and commercialization of minimally invasive technologies / devices for neurovascular disorders. The company operates through four segments, namely, aneurysm therapy, ischemic stroke and carotid artery, neurovascular malformations, and access product solutions. Further, it is worth highlighting that the company is using innovative techniques in order to develop high quality products with robust clinical research activities. This approach is likely to enable the company to strengthen their current portfolio of neurovascular devices.
MicroVention: Company Overview
| Key Parameters | Description |
| Company Logo |  |
| Year of Establisment | 1997 |
| Number of Employees | 1,001-5,000 |
| Headquarter |  |
| Neurovascular Devices |
|
Recent Developments:
In February 2024, the company participated in the Live Interventional Neuroradiology, Neurology & Neurosurgery Course Americas 2024 (LINNC Americas 2024) and International Stroke Conference-2024 (ISC-2024), held in the US, demonstrating its capabilities and innovations related to neurovascular devices. The company launched its LVIS EVO Intraluminal Support Device in the US in January 2024.
Further details on recent initiatives taken by MicroVention and other neurovascular device companies have been provided in detail in the report.
Penumbra, Expanding its Neurovascular Portfolio in Europe With Several Recent Launches
4. Penumbra
Penumbra, a US-based healthcare company offering an extensive range of products and services across three main operating segments, namely Neuro, Vascular and Immersive healthcare. Furthermore, the company offers innovative techniques such as neurovascular access, revascularization, neuro embolization, and neurosurgical evacuation to the patients suffering from neurovascular disorders.
Penumbra: Company Overview
| Key Parameters | Description |
| Company Logo |  |
| Year of Establisment | 2004 |
| Number of Employees | 1,001-5,000 |
| Headquarter |  |
| Neurovascular Devices |
|
Recent Developments:
In February 2024, the company organized an International Stroke Conference 2024, held in Arizona, dedicated to share cognizance regarding the treatment of neurovascular diseases and brain health.
More recently, the company commercially launched several products in Europe, including three reperfusion catheters Red 43, Red 72 with Sendit technology, and Red 78 in May 2024 and two traditional access catheters BMX81 and BMX96 in June 2024.
Further details on recent initiatives taken by Penumbra and other neurovascular device companies have been provided in detail in the report.
In May 2023, Stryker Acquired Cerus Endovascular, Engaged in the Design and Development of Neurointerventional Devices
5. Stryker
Stryker is a leading medical technology company specialized in providing innovative medical devices, along with services in the domain of MedSurg (Medical and Surgical), Neurotechnology and Orthopaedics. Further, within the
neurotechnology domain, the company offers minimally invasive devices for cranial, spinal and neurovascular diseases, for various procedures, including angioplasty, stenting and thrombectomy. It is worth highlighting that the company is capable of providing customized medical device technologies with an intend to improve healthcare outcomes for neurovascular diseases. Further, the firm has over 45 manufacturing and R&D facilities in over 100 countries. It is interesting to note that the firm has acquired several companies over the past five years.
Stryker: Company Overview
| Key Parameters | Description |
| Company Logo |  |
| Year of Establisment | 1941 |
| Number of Employees | 10,001+ |
| Headquarter |  |
| Neurovascular Devices |
|
Recent Developments:
In January 2024, Stryker participated in the 15th Annual Symposium on Neurovascular Disease. The firm provided details on emerging technologies, such as artificial intelligence in neurovascular and stroke imaging. In addition, the company provided information on major neurovascular trials.
Further details on recent initiatives taken by Stryker and other neurovascular device companies have been provided in detail in the report.
What About the Other Neurovascular Device Companies Around the World?
The above presentation features five top Neurovascular Device companies selected from a pool of over 50 players that we have compiled. If you're interested, you can download the Sample Report on this topic by Roots Analysis. For personalized assistance in identifying the most relevant solutions based on your specific criteria, please don't hesitate to reach out to us at sales@rootsanalysis.com.
Sources
- https://www.jnjmedtech.com/en-US/news-events/cerenovus-announces-sustainability-commitment-and-showcases-new-product-and-data
- https://www.jnjmedtech.com/en-US/news-events/cerenovus-unveils-clinical-data-and-showcases-new-product-innovations-change-trajectory
- https://www.jnjmedtech.com/en-US/neuro-thromboembolic-initiative
- https://www.healthcaremea.com/egypts-alameda-healthcare-group-and-medtronic-jointly-launch-a-new-neuroscience-center/
- https://www.qure.ai/news_press_coverages/medtronic-and-qure-ai-partner-to-advance-stroke-management-using-artificial-intelligence-ai-in-india